Saturday 17 October 2026 Export CSLT’s income statement to Excel — free account

Castlight Health, inc.

CSLT Healthcare Health Information Services

Operating cash flow growth for ten consecutive years.

2.05 0.00 0.00%

Follow CSLT

Alert me

Market cap: $332.4M
P/E: 0.0×
Fwd P/E: −18.6×
Dividend yield: —
F-score: 5/9
Altman Z: n/a
Beneish M: −4.14
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 24.17%

Capital & Financial Ratios $m

Market Cap 332.37

Revenue 142.52

Net Income (8.61)

Free Cash Flow 20.15

Net Debt (65.77)

Current Ratio 2.94

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (18.60)

P/S ratio 2.32

P/B ratio 2.60

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth (4.57%)

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2018	2019	2020	Q'21
Cash	77	59	49	66
Receivables	27	31	32	23
Inventory	—	—	—	—
Other	—	—	—	—
	108	95	85	96

	2018	2019	2020	Q'21
Payables	10	20	5	5
ST’ Debt	—	—	—	—
Other	—	—	—	—
	51	55	34	33

Compound Annual Growth %

	10y	5y	3y
Sales	—	14.27%	3.58%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.91%	(16.34%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	35	36	35	—	—
’20	39	36	35	37	147
’19	35	36	35	36	143
’18	36	38	40	42	156
’17	28	33	34	37	132

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	8	5	6	—	—
’20	(14)	3	3	3	(6)
’19	(12)	(2)	(7)	4	(17)
’18	(19)	(1)	(6)	8	(19)
’17	(11)	(4)	(8)	0	(23)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	7	5	5	—	—
’20	(16)	1	3	3	(9)
’19	(12)	(2)	(8)	3	(19)
’18	(19)	(2)	(7)	7	(21)
’17	(11)	(5)	(10)	0	(26)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.02)	(0.01)	(0.01)	—	—
’20	(0.38)	(0.03)	0.00	(0.01)	(0.41)
’19	(0.07)	(0.06)	(0.06)	(0.08)	(0.28)
’18	(0.11)	(0.10)	(0.05)	(0.03)	(0.29)
’17	(0.14)	(0.11)	(0.14)	(0.06)	(0.44)

Fiscal quarters ending in the months shown.

Group	Line	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021e
Price, $
Price, $	Low	—	—	—	—	—	—	—	—	—	—	Analyst estimates 2021–2023 Powerpack
	High	—	—	—	—	—	—	—	—	—	—
People
People	Employees	—	—	—	—	—	381	527	470	463	440
	Revenue/emp, $m	—	—	—	—	—	0.26	0.25	0.33	0.31	0.33
Income, $m
Income, $m	Revenue	—	—	—	—	—	99	132	156	143	147
	Gross margin, %	—	—	—	—	—	67.72	64.66	61.52	58.78	64.53
	EBT	—	—	—	—	—	(59)	(57)	(40)	(40)	(62)
	EBT margin, %	—	—	—	—	—	(59.45)	(43.26)	(25.39)	(27.91)	(42.39)
	Net income	—	—	—	—	—	(59)	(52)	(40)	(40)	(62)
	Depreciation	—	—	—	—	—	12	21	25	22	68
Per share, $
Per share, $	Revenue	—	—	—	—	—	0.98	1.05	1.14	0.99	0.97
	Earnings	—	—	—	—	—	(0.58)	(0.44)	(0.29)	(0.28)	(0.41)
	Cash flow	—	—	—	—	—	(0.37)	(0.19)	(0.13)	(0.12)	(0.04)
	Capex	—	—	—	—	—	(0.02)	(0.02)	(0.01)	(0.01)	(0.02)
	Free cash flow	—	—	—	—	—	(0.38)	(0.21)	(0.15)	(0.13)	(0.06)
	Book value	—	—	—	—	—	1.01	1.69	1.41	1.19	0.82
	Shares, m	—	—	—	—	—	101	126	138	145	151
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	—	—	5.05	3.61	1.91	1.35	1.34
	P/B	—	—	—	—	—	4.89	2.25	1.53	1.12	1.59
	EV/Sales	—	—	—	—	—	3.89	2.94	1.44	1.00	1.11
	EV/FCF	—	—	—	—	—	(9.94)	(14.95)	(10.93)	(7.38)	(17.75)
Cash, $m
Cash, $m	Operating cash flow	—	—	—	—	—	(37)	(23)	(19)	(17)	(6)
	Capex	—	—	—	—	—	(2)	(3)	(2)	(2)	(4)
	Free cash flow	—	—	—	—	—	(39)	(26)	(21)	(19)	(9)
Balance, $m
Balance, $m	Working capital	—	—	—	—	—	92	62	57	41	50
	Total debt	—	—	—	—	—	—	5	3	1	7
	Net debt	—	—	—	—	—	(115)	(88)	(74)	(58)	(49)
	Shareholders’ equity	—	—	—	—	—	102	212	195	173	124
Returns, %
Returns, %	ROA	—	—	—	—	—	(35.52)	(23.75)	(14.89)	(16.12)	(30.37)
	ROIC	—	—	—	—	—	0.00	(29.29)	(20.68)	(22.50)	(52.59)
	ROE	—	—	—	—	—	(53.27)	(33.11)	(19.55)	(21.77)	(41.91)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2020 · latest quarter Sep 2021

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
WEAV Weave Communications, Inc.	$594.5M	— (loss-making)	— (loss-making)	+15.52% (above 0%: growing)	n/m	+94.33% (above 0%: growing)	72.03%	(6.49%)	Compare
EVH Evolent Health, Inc	$550.6M	— (loss-making)	— (loss-making)	+46.86% (above 0%: growing)	n/m	+58.67% (above 0%: growing)	12.39%	(1.47%)	Compare
NRC National Research Corporation	$466.9M	80.6×	4.9×	+3.98% (above 0%: growing)	n/m	+101.49% (above 0%: growing)	61.67%	(9.15%)	Compare
CTEV Claritev Corporation	$404.4M	— (loss-making)	— (loss-making)	+6.59% (above 0%: growing)	n/m	+49.10% (above 0%: growing)	73.72%	9.09%	Compare
CARL Carlsmed, Inc.	$380.9M	— (loss-making)	— (loss-making)	+56.75% (above 0%: growing)	n/m	−6.84% (below 0%: shrinking)	76.78%	(58.27%)	Compare
CSLT Castlight Health, inc.	$332.4M	— (loss-making)	— (loss-making)	−0.86% (below 0%: shrinking)	n/m	+106.49% (above 0%: growing)	66.20%	(5.42%)
SPOK Spok Holdings, Inc.	$224.5M	17.7×	16.2×	−1.89% (below 0%: shrinking)	−9.09% (below 0%: shrinking)	−2.00% (below 0%: shrinking)	80.47%	15.50%	Compare
AMWL American Well Corporation	$210.6M	— (loss-making)	— (loss-making)	−26.59% (below 0%: shrinking)	n/m	+266.38% (above 0%: growing)	52.95%	(18.36%)	Compare
SY So-Young International Inc. Sponsored ADR	$198.9M	— (loss-making)	12.8×	+40.84% (above 0%: growing)	n/m	−798.37% (below 0%: shrinking)	44.11%	(8.64%)	Compare
Median of peers	$392.6M	—	12.8×	+11.06%	—	+53.89%	66.85%	(7.56%)

All 51 Health Information Services stocks →